Stockreport

Newron to Present New Analyses From and Updates on its Clinical Program Evaluating Evenamide as an Add-on Treatment for Schizophrenia at the 38th European College of Neuropsychopharmacolog...

MEIJI HOLDINGS UNSP/ADR  (MEJHY) 
NASDAQ:AMEX Investor Relations: meiji.com/global/investors
PDF Introduction of key features of landmark, potentially pivotal study ENIGMA-TRS 1, designed to demonstrate the short and long-term efficacy of evenamide as an add-on tre [Read more]